DEFA14A ·Filed Apr 7, 2026

CPT

CAMDEN PROPERTY TRUST
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001628280-26-024078
Proxy solicitation materials
Actionable Insight • Neutral

Investors should note that abstaining on Proposals 4 and 5 will effectively count as a vote against. The clarification increases voting transparency but does not alter the economic substance of the proposals. Monitor actual voting results post-meeting for shareholder sentiment on compensation plans.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CPT ▲ +14.69% at T+60d
NEUTRAL call ✓ call won +14.69% · α vs SPY +4.51% · entry $102.24 → $117.25
Entry anchored
Apr 7, 03:59 PM ET
via exchange tick
T+1d
-1.38%
call -1.38% · α -1.96%
$100.82
settled 6mo ago
T+5d
-1.18%
call -1.18% · α -4.70%
$101.03
settled 6mo ago
T+20d
+2.44%
call +2.44% · α -6.10%
$104.73
settled 5mo ago
T+60d
+14.69%
call +14.69% · α +4.51%
$117.25
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Camden Property Trust filed a proxy supplement to clarify voting requirements for two shareholder proposals related to its amended share incentive and employee share purchase plans. The supplement specifies that a majority of votes cast is required for approval, with abstentions counting as votes against and broker non-votes having no effect. This is a routine procedural update ahead of the May 8, 2026 annual meeting.

Key Facts

  • Filing is a proxy supplement for the 2026 Annual Meeting of Shareholders scheduled for May 8, 2026
  • Clarifies voting standard for Proposal 4 (Amended 2018 Share Incentive Plan) and Proposal 5 (Amended 2018 Employee Share Purchase Plan)
  • Approval requires affirmative vote of majority of shares present and entitled to vote
  • Abstentions count as votes against; broker non-votes have no effect
  • No changes to underlying proposals or financial terms disclosed

Financial Impact

Undisclosed — no new financial terms or share amounts provided in supplement

equity_compensationshare_countdilution

Risk Factors

  • Failure of equity plan approvals could limit the company's ability to grant future stock-based compensation
  • Potential shareholder opposition to equity plans if perceived as overly dilutive

Market Snapshot

Exchange
NYSE
Sector
Real Estate Investment Trusts

Investment Themes

Real Estate

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-024078
Document: 0001628280-26-024078-index-headers.html0001628280-26-024078
Document: 0001628280-26-024078-index.html0001628280-26-024078
Document: 0001628280-26-024078.txt0001628280-26-024078
5 reports for CPT
Performance horizon
Filters
Rows
Reports for CPT — sortable, filterable
TypeNow
Aug 3, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$111.03 $105.96▼ −4.57%▼ −3.33%$96.22 (−13.34%)
Jun 11, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$114.44 $113.29▼ −1.00%▼ −2.90%$96.22 (−15.92%)
Apr 30, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$104.73 $106.49▲ +1.68%▼ −3.55%$96.22 (−8.13%)
Apr 7, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$102.24 $104.73▲ +2.44%▼ −6.10%$96.22 (−5.88%)
Mar 27, 2026
27w ago
DEFA14A
NEUTRAL ★ 3/10
$96.80 $101.13▲ +4.47%▼ −8.27%$96.22 (−0.60%)
Showing 5 of 5

US Market Status

Market Open — Closes in 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access